China Universal Asset Management Co., Ltd. Xenon Pharmaceuticals Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $773 Million
- Q1 2024
A detailed history of China Universal Asset Management Co., Ltd. transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 14,520 shares of XENE stock, worth $524,462. This represents 0.08% of its overall portfolio holdings.
Number of Shares
14,520
Previous 14,520
-0.0%
Holding current value
$524,462
Previous $625,000
-0.0%
% of portfolio
0.08%
Previous 0.08%
Shares
12 transactions
Others Institutions Holding XENE
# of Institutions
228Shares Held
69MCall Options Held
307KPut Options Held
68.9K-
Avoro Capital Advisors LLC New York, NY5.67MShares$205 Million2.94% of portfolio
-
Driehaus Capital Management LLC Chicago, IL4.32MShares$156 Million2.04% of portfolio
-
Wellington Management Group LLP Boston, MA3.92MShares$142 Million0.03% of portfolio
-
Capital World Investors Los Angeles, CA2.68MShares$96.9 Million0.02% of portfolio
-
Polar Capital Holdings PLC London, X02.61MShares$94.3 Million0.7% of portfolio
About Xenon Pharmaceuticals Inc.
- Ticker XENE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,263,500
- Market Cap $2.25B
- Description
- Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...